New research published today uncovers how the blood cancer ‘steals’ parts of surrounding healthy bone marrow cells to thrive, in work that could help form new approaches to cancer treatment in the future.

Low-cost, high-volume health services account for a high percentage of unnecessary health spending, adding strain to the health care system, new UCLA-led research suggests.

A study from the University of Surrey found that a subject group of otherwise healthy men had increased levels of fat in their blood and fat stored in their livers after they had consumed a high sugar diet. 

Increasingly, transplant surgeons must initiate a tough conversation: explaining to patients what it means to accept an organ from a person who died from a drug overdose or engaged in other risky behaviors.

Predicting how climate change will affect the incidence of infectious diseases would have great public health benefits. But the relationship between climate and disease is extraordinarily complex, making such predictions difficult. Simply identifying correlations and statistical associations between climatic factors and disease won’t be enough, said Princeton University researcher Jessica Metcalf. Instead, researchers need new statistical models that incorporate both climate factors and the climate–disease relationship, accounting for uncertainties in both.

Could decreases in temperature cause heart failure and death?

The world’s first widespread human testing of a flu vaccine which researchers hope will protect more over 65-year-olds against influenza has begun in the NHS.

A new study by Osaka University scientists shows that non-labeling multiphoton microscopy (NL-MPM) can be used for quantitative imaging of cancer that is safe and requires no resection, fixation or staining of tissues. The report is expected to simplify and reduce the time of cancer diagnosis and can be read in Scientific Reports.

A new study carried out by the University of Oxford has used flat worms to look at the role of migrating stem cells in cancer.

Genetic changes that help lung cancer thrive also make it vulnerable to a promising experimental drug, according to a study led by researchers from Perlmutter Cancer Center at NYU Langone Health, and published online October 2 in Nature Medicine.